Medication for chest pain
Pro Research Analysisby 
Searched over 200M research papers
Medication for Chest Pain: An Overview of Current Research
Introduction to Chest Pain Management
Chest pain is a common and often alarming symptom that can stem from various causes, including cardiac and non-cardiac origins. Effective management of chest pain is crucial for improving patient outcomes and quality of life. This article synthesizes recent research on medications used to treat chest pain, focusing on both cardiac and non-cardiac causes.
Antidepressants for Non-Cardiac Chest Pain
Imipramine and Functional Chest Pain
Imipramine, a tricyclic antidepressant, has shown promise in reducing chest pain episodes in patients with normal coronary angiograms. Studies indicate that imipramine significantly decreases the frequency of chest pain episodes, although it does not improve overall quality of life due to a high incidence of side effects 14. A meta-analysis further supports the efficacy of antidepressants in reducing pain and psychological symptoms in patients with functional chest pain, though they are associated with increased side effects and do not significantly improve health-related quality of life .
Sertraline and Coping Skills Training
Sertraline, a selective serotonin reuptake inhibitor (SSRI), has also been studied for its effects on non-cardiac chest pain. Research suggests that sertraline, either alone or in combination with coping skills training (CST), significantly reduces pain intensity and unpleasantness. The combination of CST and sertraline appears particularly effective, also reducing pain catastrophizing and anxiety .
Pre-Hospital Treatment of Acute Coronary Syndrome
Narcotic Analgesics and Beta-Blockers
In the pre-hospital setting, managing chest pain often involves narcotic analgesics like morphine, which are effective but come with side effects. Beta-blockers, when used in combination with morphine, can enhance pain relief but also increase the risk of side effects. Nitrates are another option, providing pain relief with fewer side effects. However, the optimal combination of these medications remains unclear, and more research is needed to establish best practices .
Benzodiazepines for Anxiety and Pain Relief
Benzodiazepines are sometimes used to manage chest pain, particularly when anxiety is a contributing factor. These medications reduce anxiety, pain, and cardiovascular activation, and may also cause coronary vasodilation and prevent dysrhythmias. While benzodiazepines are generally safe and well-tolerated, their role in acute chest pain management requires further study .
Non-Pharmacological Interventions
Heat Therapy for Acute Coronary Syndrome
Local heat therapy has been investigated as a non-pharmacological intervention for chest pain in patients with acute coronary syndrome. Studies show that applying heat significantly reduces pain intensity, duration, and frequency, offering a potential alternative to pharmacological treatments with fewer side effects .
Conclusion
The management of chest pain involves a variety of pharmacological and non-pharmacological approaches. Antidepressants like imipramine and sertraline show efficacy in reducing non-cardiac chest pain, though side effects and quality of life improvements remain concerns. In the pre-hospital setting, narcotic analgesics, beta-blockers, and nitrates are commonly used, but their optimal combination is still under investigation. Benzodiazepines offer additional benefits for anxiety-related chest pain. Non-pharmacological interventions, such as heat therapy, provide promising alternatives. Further research is essential to refine these treatments and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic
Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms.
Low dose imipramine reduces chest pain in patients with chest pain and normal coronaries, but does not improve quality of life due to a high incidence of side effects.
Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus.
Oral nifedipine can decrease esophageal contraction amplitude and duration, but does not significantly relieve daily chest pain frequency or severity.
The effects of topical heat therapy on chest pain in patients with acute coronary syndrome: a randomised double-blind placebo-controlled clinical trial.
Local heat therapy effectively reduces chest pain intensity, duration, and frequency in patients with acute coronary syndrome, without requiring opioid analgesic therapy.
Treatment of Esophageal (Non-cardiac) Chest Pain: Review
Proton pump inhibitors, antidepressants, theophylline, and cognitive behavioral therapy show promise in treating esophageal chest pain, but more rigorous randomized controlled trials are needed.
DOI